You are here

  • Home
  • Archive
  • Volume 12, Issue 9
  • ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial

Article metrics

Article menu

Download PDFPDF

Rheumatology
Protocol
ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial

 

Online download statistics by month:

Online download statistics by month: September 2022 to June 2025

AbstractFullPdf
Sep 202262963087
Oct 2022719717130
Nov 202235935951
Dec 202234834520
Jan 202331030920
Feb 202324924631
Mar 2023575719
Apr 2023383721
May 2023282714
Jun 2023494913
Jul 2023434313
Aug 2023716721
Sep 2023495113
Oct 2023555429
Nov 2023535520
Dec 2023373421
Jan 2024494915
Feb 2024343518
Mar 2024232382
Apr 2024323226
May 2024434022
Jun 2024272616
Jul 2024656137
Aug 2024575428
Sep 2024302916
Oct 2024484826
Nov 2024353519
Dec 2024474631
Jan 2025515525
Feb 2025696924
Mar 2025383920
Apr 2025757635
May 2025656328
Jun 202515148
Total38973874999